News | April 16, 2025
Nissan Chemical extends supply agreement with MSD Animal Health for Fluralaner
Fluralaner invented by Nissan Chemical is the active pharmaceutical ingredient of BRAVECTO and EXZOLT,
Fluralaner invented by Nissan Chemical is the active pharmaceutical ingredient of BRAVECTO and EXZOLT,
The supply of these goods is set to commence within the first quarter of FY26
The IND application supports the next phase of development of SBO-154
Vidya will spark conversations around less discussed and important aspects of health, including intimate care and sleep issues
Around 100 million people live with COPD in China, accounting for almost 25% of all COPD cases globally
The new facility, which has a capacity of 5,000 metric tonnes, will manufacture nutraceuticals and dietary-active ingredients for human consumption.
Earlier, Cupid Limited had been eligible to supply 75% of the contract for female condoms in previous tenders
Menkes disease is a rare X-linked recessive pediatric disease caused by gene mutations of the copper transporter ATP7A
The order, part of an international framework agreement is to be executed between February to April, 2025
An investigational long-acting monoclonal antibody designed to protect infants from RSV disease during their first RSV season
Subscribe To Our Newsletter & Stay Updated
